Patents by Inventor Joseph V. Bondi

Joseph V. Bondi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11013811
    Abstract: This invention provides low molecular weight lipid-GAG and phospholipids-GAG conjugates and methods of use thereof in suppressing, inhibiting, preventing, or treating a pathogenic effect on a cell, including, inter alia, infection with intracellular pathogens.
    Type: Grant
    Filed: October 27, 2014
    Date of Patent: May 25, 2021
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Saul Yedgar, Yuval Cohen, Joseph V. Bondi
  • Publication number: 20150119567
    Abstract: This invention provides low molecular weight lipid-GAG and phospholipids-GAG conjugates and methods of use thereof in suppressing, inhibiting, preventing, or treating a pathogenic effect on a cell, including, inter alia, infection with intracellular pathogens.
    Type: Application
    Filed: October 27, 2014
    Publication date: April 30, 2015
    Inventors: SAUL YEDGAR, YUVAL COHEN, JOSEPH V BONDI
  • Publication number: 20110130555
    Abstract: This invention provides low molecular weight lipid-GAG and phospholipids-GAG conjugates and methods of use thereof in suppressing, inhibiting, preventing, or treating a pathogenic effect on a cell, including, inter alia, infection with intracellular pathogens.
    Type: Application
    Filed: May 11, 2010
    Publication date: June 2, 2011
    Inventors: Saul Yedgar, Yuval Cohen, Joseph V. Bondi
  • Patent number: 4942037
    Abstract: A transdermal delivery system suitable for the drug (4aR-trans )-3,4,4a,5,6,10b-hexahydro-4-propyl-2H-naphth[1,2-b]-1,4-oxazin-9-ol over an extended period of time is described.
    Type: Grant
    Filed: June 2, 1988
    Date of Patent: July 17, 1990
    Assignee: Merck & Co., Inc.
    Inventors: Joseph V. Bondi, Alice E. Loper
  • Patent number: 4756710
    Abstract: A method and device for delivering acidic or basic drugs in a controlled delivery system is described.
    Type: Grant
    Filed: March 7, 1986
    Date of Patent: July 12, 1988
    Assignee: Merck & Co., Inc.
    Inventors: Joseph V. Bondi, Alice E. Loper, Edward M. Cohen
  • Patent number: 4752478
    Abstract: A method and device for administering timolol for an extended period is described. By the method and device, transdermal application of timolol may be accomplished with substantially no irritation to the skin.
    Type: Grant
    Filed: December 17, 1984
    Date of Patent: June 21, 1988
    Assignee: Merck & Co., Inc.
    Inventors: Joseph V. Bondi, Alice E. Loper, Edward M. Cohen
  • Patent number: 4730013
    Abstract: Ocular inserts with or without pharmacologically active agents comprising low molecular weight polymers have a lower propensity to cause blurred vision compared with inserts prepared from high molecular weight hydroxypropyl cellulose. When an enteric coating material is included as a constituent of the matrix there is provided a means for controlling and predicting dissolution rates of the insert to yield a prolonged residence time.
    Type: Grant
    Filed: March 2, 1987
    Date of Patent: March 8, 1988
    Assignee: Merck & Co., Inc.
    Inventors: Joseph V. Bondi, Richard J. Harwood
  • Patent number: 4594884
    Abstract: A device for measuring diffusion, particularly adaptable to measuring diffusion of drugs, is described.
    Type: Grant
    Filed: June 21, 1984
    Date of Patent: June 17, 1986
    Assignee: Merck & Co., Inc.
    Inventors: Joseph V. Bondi, Lucille A. Grabowski
  • Patent number: 4439194
    Abstract: A drug delivery system designed to deliver water and drug to the site of administration is composed of a core of an aqueous solubulizing system in a wax housing, which melts at body temperature, surrounded by a matrix of drug and water-dispersible excipients. The entire unit may also be coated with a semi-permeable membrane to modulate drug release.
    Type: Grant
    Filed: September 8, 1981
    Date of Patent: March 27, 1984
    Assignee: Merck & Co., Inc.
    Inventors: Richard J. Harwood, Joseph V. Bondi